On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors (2020)
Source: RSC Medicinal Chemistry. Unidades: PUSP-RP, IQSC, BIOENGENHARIA
Assunto: DOENÇA DE CHAGAS
ABNT
BONATT, Vinicius; MONTANARI, Carlos Alberto; SILVA, Daniel G da; et al. On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors. RSC Medicinal Chemistry, Cambridge, Royal Society of Chemistry - RSC, v. 11, n. 11, p. 1275-1284, 2020. Disponível em: < https://pubs.rsc.org/en/content/articlehtml/2020/md/d0md00097c > DOI: 10.1039/D0MD00097C.APA
Bonatt, V., Montanari, C. A., Silva, D. G. da, Cedron, R., Tezuka, D. Y., Albuquerque, S. de, et al. (2020). On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors. RSC Medicinal Chemistry, 11( 11), 1275-1284. doi:10.1039/D0MD00097CNLM
Bonatt V, Montanari CA, Silva DG da, Cedron R, Tezuka DY, Albuquerque S de, Moraes CB, Franco CH, Lameira J, Leitão A, Batista PHJ, Cianni L, Vita D de. On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors [Internet]. RSC Medicinal Chemistry. 2020 ; 11( 11): 1275-1284.Available from: https://pubs.rsc.org/en/content/articlehtml/2020/md/d0md00097cVancouver
Bonatt V, Montanari CA, Silva DG da, Cedron R, Tezuka DY, Albuquerque S de, Moraes CB, Franco CH, Lameira J, Leitão A, Batista PHJ, Cianni L, Vita D de. On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors [Internet]. RSC Medicinal Chemistry. 2020 ; 11( 11): 1275-1284.Available from: https://pubs.rsc.org/en/content/articlehtml/2020/md/d0md00097c